Radiation treatment for breast cancer may increase incidence of nonkeratinocyte skin cancer
1. Amongst a cohort of breast cancer survivors, those that were treated with radiation had a higher risk of developing ...
Tag: Breast Cancer
Atrial fibrillation risk greater in younger breast cancer survivors compared to older survivors in Korea
1. In a Korean cohort of breast cancer survivors, younger survivors had an increased risk of incident atrial fibrillation compared ...
2 Minute Medicine Rewind March 4, 2024
Use of tobacco products and suicide attempts among elementary school-aged children 1. In a cohort of US children aged 9-10, ...
Presence of unmet social needs associated with lower utilization of breast cancer screening programs
1. Having a greater number of unmet social needs was associated with lower utilization of screening mammography services, as well ...
#VisualAbstract: Stereotactic body radiotherapy enhances survival in patients with non-small cell lung cancer
1. Median progression-free survival was greater in the SBRT group than in the standard-of-care group. 2. Patients with NSCLC displayed ...
Enobosarm in AR-positive, ER-positive, and HER2-Negative Advanced Breast Cancer
1. The clinical benefit rate was 32% in the 9 mg group and 29% in the 18 mg group. 2. ...
Stereotactic body radiotherapy enhances survival in patients with non-small cell lung cancer
1. Median progression-free survival was greater in the SBRT group than in the standard-of-care group. 2. Patients with NSCLC displayed ...
Worse breast cancer death rates for non-screen detected ductal carcinoma situ
1. Women with non-screen detected ductal carcinoma in situ had worse outcomes for the 25 years following their diagnosis. 2. ...
#VisualAbstract: Atezolizumab With Carboplatin in Patients With Metastatic Triple-Negative Breast Cancer
1. Progression-free survival was 4.1 months in the combination arm vs 2.2 months in the monotherapy arm with an HR ...
Pyrotinib in combination with trastuzumab and docetaxel promising for HER2 positive metastatic breast cancer
1. This phase 3 randomised trial demonstrated that compared with placebo in combination with trastuzumab and docetaxal, pyrotinib in the ...
